|
|
???tair.name??? >
???browser.page.title.author???
|
"chu c j"???jsp.browse.items-by-author.description???
Showing items 1-18 of 18 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 元智大學 |
Jan-22 |
Implementation and experience of an innovative smart patient care system: a cross-sectional study
|
Wen, M. H.; Bai, D.; Lin, S.; Chu, C. J.; Hsu Y.-L. |
| 臺大學術典藏 |
2022-01-24T09:31:21Z |
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV
|
CHUN-JEN LIU; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; Chen P.-J. |
| 臺大學術典藏 |
2021-09-04T06:11:39Z |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study
|
Manns M.; Pol S.; Jacobson I.M.; Marcellin P.; Gordon S.C.; Peng C.-Y.; Chang T.-T.; Everson G.T.; Heo J.; Gerken G.; Yoffe B.; Towner W.J.; Bourliere M.; Metivier S.; Chu C.-J.; Sievert W.; Bronowicki J.-P.; Thabut D.; Lee Y.-J.; JIA-HORNG KAO; McPhee F.; Kopit J.; Mendez P.; Linaberry M.; Hughes E.; Noviello S. |
| 臺大學術典藏 |
2021-09-04T06:11:14Z |
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection
|
JIA-HORNG KAO; Chien R.-N.; Chang T.-T.; Peng C.-Y.; Hu T.-H.; Lo G.-H.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Han L.; Mo H.; Mathias A.; Brainard D.M.; Sheen I.-S.; Hsu Y.-C.; Chu C.-J.; Chuang W.-L. |
| 臺大學術典藏 |
2021-09-04T06:11:14Z |
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus
|
Chuang W.-L.; Chien R.-N.; Peng C.-Y.; Chang T.-T.; Lo G.-H.; Sheen I.-S.; Wang H.-Y.; Chen J.-J.; Yang J.C.; Knox S.J.; Gao B.; Garrison K.L.; Mo H.; Pang P.S.; Hsu Y.-C.; Hu T.-H.; Chu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:17:13Z |
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
|
JIA-HORNG KAO; Yu M.-L.; Peng C.-Y.; Heo J.; Chu C.-J.; Chang T.-T.; Lee Y.-J.; Hu T.-H.; Yoon K.T.; Paik S.W.; Lim Y.S.; Ahn S.H.; Isakov V.; McPhee F.; Hu W.; Scott Swenson E.; Yin P.D.; Treitel M. |
| 臺大學術典藏 |
2021-09-04T05:16:20Z |
Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study
|
Yu M.-L.; Tsai W.-L.; Chu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-07-03T03:33:39Z |
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV
|
Liu C.-J.; Chuang W.-L.; Sheen I.-S.; Wang H.-Y.; Chen C.-Y.; Tseng K.-C.; Chang T.-T.; Massetto B.; Yang J.C.; Yun C.; Knox S.J.; Osinusi A.; Camus G.; Jiang D.; Brainard D.M.; McHutchison J.G.; Hu T.-H.; Hsu Y.-C.; Lo G.-H.; Chu C.-J.; Chen J.-J.; Peng C.-Y.; Chien R.-N.; PEI-JER CHEN |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
|
Kao, J.-H.;Yu, M.-L.;Peng, C.-Y.;Heo, J.;Chu, C.-J.;Chang, T.-T.;Lee, Y.-J.;Hu, T.-H.;Yoon, K.T.;Paik, S.W.;Lim, Y.S.;Ahn, S.H.;Isakov, V.;Mcphee, F.;Hu, W.;Scott Swenson, E.;Yin, P.D.;Treitel, M.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:01:49Z |
Detection of electrically neutral and nonpolar molecules in ionic solutions using silicon nanowires
|
Wu, Y. P.; Chu, C. J.; Tsai, L. C.; Su, Y. W.; Chen, P. H.; Moodley, M. K.; Huang, D.; Chen, Y. T.; Yang, Y. J.; Chen, C. D.; YIT-TSONG CHEN |
| 臺大學術典藏 |
2018-09-10T14:59:23Z |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study
|
Manns, M.;Pol, S.;Jacobson, I.M.;Marcellin, P.;Gordon, S.C.;Peng, C.-Y.;Chang, T.-T.;Everson, G.T.;Heo, J.;Gerken, G.;Yoffe, B.;Towner, W.J.;Bourliere, M.;Metivier, S.;Chu, C.-J.;Sievert, W.;Bronowicki, J.-P.;Thabut, D.;Lee, Y.-J.;Kao, J.-H.;Mcphee, F.;Kopit, J.;Mendez, P.;Linaberry, M.;Hughes, E.;Noviello, S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:47:41Z |
Study on blood cultures and bacteria counts in the blood of paratyphoid fever A patients.
|
Wang, S. K.; Chu, C. J.; Sun, P. S.; Shan, D. S.; Kong, F. L.; Liu, H. Y.; Wu, Q.; Yang, R. S.; Yao, Y. B.楊榮森; Wang, S. K.; Chu, C. J.; Sun, P. S.; Shan, D. S.; Kong, F. L.; Liu, H. Y.; Wu, Q.; Yang, R. S.; Yao, Y. B.; 楊榮森; RONG-SEN YANG; Kong, FL; liu, HY; Wu, Q; YAo, YB; Wang, SK; Chu, CJ; Sun, PS; Shan, DS |
| 國立成功大學 |
2007-12 |
Control and detection of organosilane polarization on nanowire field-effect transistors
|
Lin, M. C.; Chu, C. J.; Tsai, L. C.; Lin, H. Y.; Wu, C. S.; Wu, Y. P.; Wu, Y. N.; Shieh, Dar-Bin; Su, Y. W.; Chen, C. D. |
| 國立彰化師範大學 |
2007 |
Control and Detection of Organosilane Polarization on Nanowire Field-Effect Transistors
|
Lin, M. C. ; Chu, C. J. ; Tsai, L. C. ; Lin, H. Y. ; Wu, Cen-Shawn; Wu, Y. P. ; Wu, Y. N. ; Shieh, D. B. ; Su, Y. W. ; Chen, C. D. |
| 國立成功大學 |
2004 |
Atomization and mixing characteristics of an unlike-doublet impinging-jet
|
Lai, Wei-Hsiang; Huang, W.; Chu, C. J. |
| 國立臺灣大學 |
1994 |
The depositional time of the Linkou Formation as revealed by the zircon FTD ages for Quaternary volcanic rocks in northern Taiwan
|
Tien, J.L.; Wang, W.S.; Chu, C.J.; Chen, C-H. |
| 國立臺灣大學 |
1990 |
Efficiency of Cytoplasmic Delivery by PH-Sensitive Liposomes to Cells in Culture
|
Chu, C. J.; Dijkstra, J.; 賴明宗; Hong, K.; Szoka, F. C.; Chu, C. J.; Dijkstra, J.; Lai, M. Z.; Hong, K.; Szoka, F. C. |
| 國立臺灣大學 |
1987 |
Lysis of Primary Hepatic Tumors by Lymphokine Activated Killer Cells
|
謝貴雄; Shu, S.; Lee, C. S.; Chu, C. J.; Yang, C. S.; Chang, K. J.; Hsieh, Kue-Hsiung; Shu, S.; Lee, C. S.; Chu, C. J.; Yang, C. S.; Chang, K. J. |
Showing items 1-18 of 18 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
